Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.
Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check4 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4, a minor metadata change that does not alter study content, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check11 days agoChange DetectedNo changes to core study data were detected; only minor UI adjustments in the page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a dedicated Locations section with detailed site entries across multiple states and countries, and removed prior state-level location groupings.SummaryDifference1%
- Check34 days agoChange DetectedThe screenshots show the same Study Details page for NCT04816604 with no additions or deletions to core sections; minor visual tweaks may be present but do not alter the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check41 days agoChange DetectedNo significant changes to the study record were observed. Updates seem to be routine informational additions, such as new publications, and minor formatting changes.SummaryDifference0.1%
- Check48 days agoChange DetectedThe study locations have been updated to 28 sites, with Oregon Health & Science University (Portland, OR) and Lundquist Institute at Harbor-UCLA (Torrance, CA) removed from the list.SummaryDifference0.4%
Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.